Achieve life sciences announces proposed public offering

Seattle and vancouver, bc, nov. 30, 2020 /prnewswire/ -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced a proposed...

ACHV Ratings Summary

ACHV Quant Ranking